CFCI
Comprehensive Financial Consultants Institutional’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Sell |
4,968
-30
| -0.6% | -$23.4K | 1.27% | 23 |
|
|
2025
Q1 | $4.13M | Buy |
4,998
+347
| +7% | +$287K | 1.47% | 18 |
|
|
2024
Q4 | $3.59M | Buy |
4,651
+117
| +3% | +$90.3K | 1.31% | 24 |
|
|
2024
Q3 | $4.02M | Sell |
4,534
-3
| -0.1% | -$2.66K | 1.47% | 20 |
|
|
2024
Q2 | $4.11M | Buy |
4,537
+404
| +10% | +$366K | 1.61% | 12 |
|
|
2024
Q1 | $3.22M | Sell |
4,133
-32
| -0.8% | -$24.9K | 1.33% | 23 |
|
|
2023
Q4 | $2.43M | Sell |
4,165
-33
| -0.8% | -$19.2K | 1.13% | 28 |
|
|
2023
Q3 | $2.25M | Sell |
4,198
-21
| -0.5% | -$11.3K | 1.18% | 27 |
|
|
2023
Q2 | $1.89M | Sell |
4,219
-280
| -6% | -$125K | 1% | 34 |
|
|
2023
Q1 | $1.55M | Sell |
4,499
-20
| -0.4% | -$6.87K | 0.87% | 33 |
|
|
2022
Q4 | $1.62M | Sell |
4,519
-53
| -1% | -$19K | 0.98% | 33 |
|
|
2022
Q3 | $1.52M | Buy |
4,572
+816
| +22% | +$271K | 1% | 31 |
|
|
2022
Q2 | $1.22M | Sell |
3,756
-1
| -0% | -$323 | 0.86% | 37 |
|
|
2022
Q1 | $1.12M | Buy |
3,757
+10
| +0.3% | +$2.97K | 0.78% | 42 |
|
|
2021
Q4 | $939K | Buy |
+3,747
| New | +$939K | 0.6% | 60 |
|